Evaluation of Celecoxib Effects on Amlodipine in Subjects With Existing Hypertension Requiring Antihypertensives
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 105 participants.
Also called NCT02979197
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 105 participants
- Sponsor
- Kitov Pharma Ltd
- Registry
-
NCT02979197 -
2016-002214-47
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT02979197. Randomized; triple masking; primary purpose treatment. Start 2016-11-03 (actual); primary completion 2017-07-21 (actual). Results posted on 2019-10-21.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluation of Celecoxib Effects on Amlodipine in Subjects With Existing Hypertension Requiring Antihypertensives
- Condition
- Hypertension
- Intervention (Drug)
- OE 10 mg amlodipine besylate tablet
- Intervention (Drug)
- OE 200 mg celecoxib capsule
- Intervention (Drug)
- Matched placebo for OE amlodipine besylate tablet
- Intervention (Drug)
- Matched placebo for OE celecoxib capsule
- Lead sponsor
- Kitov Pharma Ltd
Record details
- Record id
cardio:ct-nct02979197- Content hash
c348d9044a857305d78c91bdc3276284f8d51bfac0f2d7da9762a26bd6d0b50f